PTEN genomic deletion predicts prostate cancer recurrence and is associated with low AR expression and transcriptional activity

BACKGROUND: Prostate cancer (PCa), a leading cause of cancer death in North American men, displays a broad range of clinical outcome from relatively indolent to lethal metastatic disease. Several genomic alterations have been identified in PCa which may serve as predictors of progression. PTEN, (10q...

Descripción completa

Detalles Bibliográficos
Autores principales: Choucair, Khalil, Ejdelman, Joshua, Brimo, Fadi, Aprikian, Armen, Chevalier, Simone, Lapointe, Jacques
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3527151/
https://www.ncbi.nlm.nih.gov/pubmed/23171135
http://dx.doi.org/10.1186/1471-2407-12-543

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3527151/
https://www.ncbi.nlm.nih.gov/pubmed/23171135
http://dx.doi.org/10.1186/1471-2407-12-543

Ejemplares similares